The Pennsylvania Department of Health (PA DOH) is hosting a virtual session with the Drug Enforcement Administration (DEA) Philadelphia Division to discuss pharmacy best practices in ordering and dispensing controlled substances, particularly medications for opioid use disorder (MOUD) like buprenorphine. This session, scheduled on Wednesday, April 24 from 12:30 pm – 2:00 pm, aims to address concerns raised during PA DOH’s Fall 2023 listening sessions on patient access to controlled substances. Participants can register for the session using this form and are encouraged to submit questions in advance by Friday, April 19, 2024. Even if unable to attend, individuals can still submit questions for a later response. Please submit inquiries via email. This collaborative learning opportunity is crucial, and recipients are encouraged to share the invitation with interested parties.